EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of co-administration of lactobacilli S-layer proteins on immune response against S-layer proteins from pathogenic Clostridioides difficile

Matías H Assandri, Mariano Malamud, Natalin J Valeff, Fernando M Trejo, Maria de Los A Serradell

Journal of Medical Microbiology · 2025

DOI: 10.1099/jmm.0.002068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2025. Verfasst von Matías H Assandri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cátedra de Microbiología, Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata, Bueno…. Hauptthemen laut MEDLINE: Clostridioides difficile, Membrane Glycoproteins, Bacterial Proteins, Lactobacillus. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, Universidad Nacional Arturo Jauretche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vaccine adjuvants are essential for enhancing and directing specific immune responses. S-layer proteins (SLPs), which coat the surface of many prokaryotes, can induce a variety of responses, including pro- and anti-inflammatory effects. We have previously shown that the SLP from Lentilactobacillus kefiri CIDCA 8348 enhances antigen-specific cellular responses. Hypothesis. The immunostimulatory activity of SLPs from L. kefiri strains could enhance the specific immune response against the SLP from the pathogen Clostridioides difficile, which is emerging as an interesting target for vaccine development.

Aim

The aim of this study was to evaluate the effect of SLPs from non-pathogenic L . kefiri strains (SLP-Lk) on the immune response against SLPs from pathogenic C. difficile strains (SLP-Cd), using in vitro and in vivo experiments. Methodology. We evaluated the immunostimulatory ability of both SLP-Lk and SLP-Cd, either alone or in combination, on RAW 264.7 macrophages by measurement of secreted IL-6 after 24 h of stimulation or by determination of cytokine mRNA expression after 4 h of incubation with stimuli. Regarding the results, we assessed the impact of SLP-Lk on the levels of anti-SLP-Cd-specific IgG in mouse sera.

Results

Among the five SLP-Lk evaluated, only SLP-Lk 8343 and SLP-Lk 83111 increased IL-6 secretion by RAW 264.7 cells, showing a dose–response behaviour, with no stimulation at 2.5 µg ml −1 . In contrast, neither SLP-Cd 117 nor SLP-Cd 43255 induced IL-6 secretion by macrophages at 30 µg ml −1 . However, when RAW 264.7 cells were incubated with a mixture of SLP-Lk 8343 or SLP-Lk 83111 (at 2.5 µg ml −1 ) and SLP-Cd 117 or SLP-Cd 43255 (at 30 µg ml −1 ), IL-6 secretion increased significantly, irrespective of the SLP-Lk/SLP-Cd pair analysed. Finally, we found that the intraperitoneal co-administration of SLP-Lk 83111 resulted in a significant increase in serum levels of anti-SLP-Cd 43255-specific IgG in immunized mice.

Conclusion

The ability of SLP-Lk 83111 to enhance the activation of antigen-presenting cells induced by SLP-Cd 43255 correlates with a significant increase in specific antibodies in the sera of mice immunized with SLP-Cd 43255. Further research is required to elucidate the roles of these anti-SLP-Cd antibodies in the context of C. difficile infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileMembrane GlycoproteinsBacterial ProteinsLactobacillusAdjuvants, ImmunologicAnimalsMiceRAW 264.7 CellsInterleukin-6FemaleMacrophagesMice, Inbred BALB CCytokinesAntibodies, Bacterial

Stichwörter der Autor:innen

Clostridioides difficileLentilactobacillus kefiriS-layeradjuvantsmacrophage activation

Substanzen

S-layer proteinsMembrane GlycoproteinsBacterial ProteinsInterleukin-6Adjuvants, ImmunologicCytokinesAntibodies, Bacterial

Autor:innen und Institutionen

  • Cátedra de Microbiología, Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata, Buenos Aires, Argentina.
  • Instituto de Ciencias de la Salud, Universidad Nacional Arturo Jauretche, Florencio Varela, Buenos Aires, Argentina.
  • Present address: Medical Research Council for Medical Mycology, University of Exeter, Exeter, UK.
  • Present address: Centro de Estudios Farmacológicos y Botánicos (CEFYBO), UBA-CONICET, Buenos Aires, Argentina.
  • Centro de Investigación y Desarrollo en Ciencia y Tecnología de los Alimentos (CIDCA), CCT La Plata CONICET-UNLP-CIC, La Plata, Buenos Aires, Argentina.

Förderung

  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • Universidad Nacional Arturo Jauretche

Zitieren

APA

Assandri, M. H., Malamud, M., Valeff, N. J., Trejo, F. M., & Serradell, M. L. A. (2025). Effect of co-administration of lactobacilli S-layer proteins on immune response against S-layer proteins from pathogenic Clostridioides difficile. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.002068

Vancouver

Assandri MH, Malamud M, Valeff NJ, Trejo FM, Serradell MLA. Effect of co-administration of lactobacilli S-layer proteins on immune response against S-layer proteins from pathogenic Clostridioides difficile. Journal of Medical Microbiology. 2025. doi:10.1099/jmm.0.002068

BibTeX
@article{Assandri2025,
  author = {Assandri, Matías H and Malamud, Mariano and Valeff, Natalin J and Trejo, Fernando M and Serradell, Maria de Los A},
  title = {Effect of co-administration of lactobacilli S-layer proteins on immune response against S-layer proteins from pathogenic Clostridioides difficile},
  journal = {Journal of Medical Microbiology},
  year = {2025},
  doi = {10.1099/jmm.0.002068}
}
Kostenlos starten →